MedPath

Effect of Audiovisual Education on Breast Cancer

Not Applicable
Active, not recruiting
Conditions
Breast Cancer
Registration Number
NCT06898229
Lead Sponsor
Mehmet Akif Ersoy University
Brief Summary

This study was conducted as a double-blind randomised controlled trial to determine the effect of education using audio-visual methods and simulation techniques on breast cancer screening and breast cancer fears in illiterate women. The study was conducted in the villages of a district in the south of Turkey with a distance of over 100 km to health institutions. The sample size of the study was calculated with the G\*Power 3.1 programme based on the mean breast cancer fear scores (22.42±8.30 for those without family history and 28.14±6.23 for those with family history) in a study, with a 95% confidence interval, 5% margin of error, 0.92 effect size and 95% power. As a result of this analysis, the minimum sample size required was determined as 64 people in total. However, a total of 120 women were included in the study in order to increase the power of the research, to prevent possible data loss and to make the results more reliable. Participants were divided into intervention (n=60) and control (n=60) groups by simple random sampling method.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
160
Inclusion Criteria
  1. Being between the ages of 40-69 (Republic of Turkey Ministry of Health, 2020a).
  2. Being a woman living in rural areas.
  3. Being an illiterate woman.
  4. Not being diagnosed with breast cancer.
  5. Not being pregnant, breastfeeding or puerperant.
  6. Accepting to participate in the study.
  7. Absence of a mental illness.
  8. No communication barriers
Exclusion Criteria
  1. Not having completed the given training sessions
  2. Having had problems with breast cancer before.
  3. Having breast conserving surgery for any reason.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Champion Breast Cancer Fear Scale5-10 minutes

The Scale is an 8-item measurement tool developed by Victoria Champion et al. in 2004. In the original study of the scale, Cronbach's alpha coefficient was found to be 0.91 for African-American and white women and 0.94 for African-American women. This scale was developed to determine the relationship between breast cancer, mammography behaviour and women's emotional reactions and is a Likert-type scale scored from 1 to 5. The highest score to be obtained from the scale is 40 and the lowest score is 8. In the evaluation of the scores; 8-15 points indicate low level fear, 16-23 points indicate medium level fear and 24-40 points indicate high level fear. Breast Cancer Fear Scale was adapted into Turkish by Seçginli in 2012.

Secondary Outcome Measures
NameTimeMethod
Post-Training Screening Behaviour Follow-up Form5-10 minutes

This form was used as a post-test after the training and follow-up of the women. With this form, it was determined which of the early diagnosis practices such as CHC, MMC and mammography the women performed.

Trial Locations

Locations (1)

Burdur Mehmet Akif Ersoy University

🇹🇷

Burdur, Turkey

Burdur Mehmet Akif Ersoy University
🇹🇷Burdur, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.